$11.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | UTHR United Therapeutics Corp Del | 2.8M | +5.6% | $1.5B | 13.5% |
| 2 | ASND Ascendis Pharma A/S | 5.1M | — | $1.4B | 12.2% |
| 3 | KRYS Krystal Biotech Inc | 2.9M | +0.0% | $1.1B | 9.6% |
| 4 | MDGL Madrigal Pharmaceuticals Inc | 1.8M | +0.8% | $984M | 8.8% |
| 5 | ARGX Argenx Se | 1.0M | +0.0% | $928M | 8.3% |
| 6 | ARWR Arrowhead Pharmaceuticals In | 11.4M | +6.1% | $926M | 8.3% |
| 7 | KYMR Kymera Therapeutics Inc | 7.5M | +0.0% | $857M | 7.7% |
| 8 | RVMD Revolution Medicines Inc | 2.3M | −2.0% | $430M | 3.9% |
| 9 | CYTK Cytokinetics Inc | 5.0M | +50.0% | $426M | 3.8% |
| 10 | CELC Celcuity Inc | 3.4M | +0.7% | $356M | 3.2% |
| 11 | GPCR Structure Therapeutics Inc | 6.6M | +0.0% | $352M | 3.2% |
| 12 | XENE Xenon Pharmaceuticals Inc | 5.8M | +0.0% | $349M | 3.1% |
| 13 | DFTX Definium Therapeutics Inc | 7.2M | +43.8% | $338M | 3.0% |
| 14 | UNIQURE NV Uniqure Nv | 6.7M | +12.9% | $310M | 2.8% |
| 15 | VERA Vera Therapeutics Inc | 5.7M | −2.8% | $246M | 2.2% |
| 16 | TSHA Taysha Gene Therapies Inc | 23.9M | +10.1% | $163M | 1.5% |
| 17 | OCUL Ocular Therapeutix Inc | 12.5M | +1.8% | $123M | 1.1% |
| 18 | DMRA Damora Therapeutics Inc | 3.8M | +0.0% | $98M | 0.9% |
| 19 | COAG Hemab Therapeutics Hldgs Inc | 1.9M | — | $71M | 0.6% |
| 20 | GHRS Gh Research Plc | 1.8M | +0.0% | $48M | 0.4% |
| 21 | VRDN Viridian Therapeutics Inc | 2.5M | +66.7% | $46M | 0.4% |
| 22 | SEPN Septerna Inc | 1.3M | +0.0% | $45M | 0.4% |
| 23 | AVTX Avalo Therapeutics Inc | 2.3M | +65.5% | $43M | 0.4% |
| 24 | FTH Faeth Therapeutics Inc | 1.4M | — | $36M | 0.3% |
| 25 | WHWK Whitehawk Therapeutics Inc | 2.8M | +0.0% | $13M | 0.1% |
| 26 | LXEO Lexeo Therapeutics Inc | 1.5M | −20.6% | $7M | 0.1% |